FDA Inspection 787742 — Biomat USA Inc.

Biomat USA Inc. — FEI 3005600079

The FDA completed an inspection of Biomat USA Inc. on Jun 27, 2012 in Canton, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 27, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Canton, OH (United States)

Citations

IDCFRDescription
25521 CFR 640.31Donor eligibility
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.